919 results match your criteria: "U1068; Aix-Marseille Universite[Affiliation]"

Background: Different liquid chromatography tandem mass spectrometry (LC-MS/MS) methods have been published for quantification of monoclonal antibodies (mAbs) in plasma but thus far none allowed the simultaneous quantification of several mAbs, including immune checkpoint inhibitors. We developed and validated an original multiplex LC-MS/MS method using a ready-to-use kit to simultaneously assay 7 mAbs (i.e.

View Article and Find Full Text PDF

Targeting REG3β limits pancreatic ductal adenocarcinoma progression through CTGF downregulation.

Cancer Lett

August 2021

Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, 163 Avenue de Luminy, 13288, Marseille, France. Electronic address:

Article Synopsis
  • The interaction between tumor cells and their surrounding microenvironment is crucial for the progression of pancreatic ductal adenocarcinoma (PDAC) and presents potential therapeutic targets.
  • REG3β, a factor produced by the tumor's far microenvironment, promotes PDAC growth, and targeting it with specific antibodies can limit tumor expansion in mice models.
  • The study further reveals that REG3β activates CTGF, and inhibiting REG3β reduces CTGF levels, indicating that REG3β's effect on PDAC progression is mediated by CTGF over-activation, suggesting REG3β as a promising target for PDAC treatment.
View Article and Find Full Text PDF

Mouth Washing Impaired SARS-CoV-2 Detection in Saliva.

Diagnostics (Basel)

August 2021

Unité de Parasitologie et Entomologie, Département de Microbiologie et Maladies Infectieuses, Institut de Recherche Biomédicale des Armées, 13005 Marseille, France.

Background: A previous study demonstrated the performance of the Salivette (SARSTEDT, Numbrecht, Germany) as a homogeneous saliva collection system to diagnose COVID-19 by RT-qPCR, notably for symptomatic and asymptomatic patients. However, for convalescent patients, the corroboration of molecular detection of SARS-CoV-2 in paired nasopharyngeal swabs (NPS) and saliva samples was unsatisfactory.

Objectives: The aim of the present work was to assess the concordance level of SARS-CoV-2 detection between paired sampling of NPSs and saliva collected with Salivette at two time points, with ten days of interval.

View Article and Find Full Text PDF

Optimization and Standardization of Human Saliva Collection for MALDI-TOF MS.

Diagnostics (Basel)

July 2021

Unité Parasitologie et Entomologie, Département Microbiologie et Maladies Infectieuses, Institut de Recherche Biomédicale des Armées, 13005 Marseille, France.

SARS-CoV-2 outbreak led to unprecedented innovative scientific research to preclude the virus dissemination and limit its impact on life expectancy. Waiting for the collective immunity by vaccination, mass-testing, and isolation of positive cases remain essential. The development of a diagnosis method requiring a simple and non-invasive sampling with a quick and low-cost approach is on demand.

View Article and Find Full Text PDF

The association of Greig syndrome and mastocytosis reveals the involvement of the hedgehog pathway in advanced mastocytosis.

Blood

December 2021

Laboratory of Molecular Mechanisms of Hematologic Disorders and Therapeutic Implications, INSERM Unité Mixte de Recherche (UMR) 1163, Paris-Centre University, Imagine Institute, Paris, France.

Mastocytosis is a heterogeneous disease characterized by an abnormal accumulation of mast cells (MCs) in 1 or several organs. Although a somatic KIT D816V mutation is detected in ∼85% of patients, attempts to demonstrate its oncogenic effect alone have repeatedly failed, suggesting that additional pathways are involved in MC transformation. From 3 children presenting with both Greig cephalopolysyndactyly syndrome (GCPS, Mendelian Inheritance in Man [175700]) and congenital mastocytosis, we demonstrated the involvement of the hedgehog (Hh) pathway in mastocytosis.

View Article and Find Full Text PDF

Pharmacokinetics and pharmacogenetics of liposomal cytarabine in AML patients treated with CPX-351.

J Control Release

October 2021

SMARTc, CRCM Inserm U1068, Aix Marseille Univ, France; COMPO CRCM Inserm U1068 CNRS UMR 7258 Aix Marseille Univ & Inria Centre de recherches Sophia Méditerranée, France; Pharmacy, La Conception University Hospital of Marseille, Marseille, France.

Article Synopsis
  • CPX-351 is a liposomal formulation of cytarabine and daunorubicin used to treat Acute Myeloid Leukemia (AML), with significant variation in pharmacokinetics based on patients' cytidine deaminase (CDA) activity.
  • A study involving 9 AML patients found that Poor Metabolizers (PM) had higher cytarabine levels and a sustained exposure compared to Extensive Metabolizers (EM), indicating CDA status significantly affects drug pharmacokinetics.
  • The overall response rate was 75%, but 56% of patients experienced severe non-hematological toxicities, highlighting a potential risk associated with higher drug exposure, especially in PM individuals.
View Article and Find Full Text PDF

LDL receptor-peptide conjugate as in vivo tool for specific targeting of pancreatic ductal adenocarcinoma.

Commun Biol

August 2021

CRCM, Aix-Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes (IPC), Marseille, France.

Despite clinical advances in diagnosis and treatment, pancreatic ductal adenocarcinoma (PDAC) remains the third leading cause of cancer death, and is still associated with poor prognosis and dismal survival rates. Identifying novel PDAC-targeted tools to tackle these unmet clinical needs is thus an urgent requirement. Here we use a peptide conjugate that specifically targets PDAC through low-density lipoprotein receptor (LDLR).

View Article and Find Full Text PDF

A central goal of precision oncology is to administer an optimal drug treatment to each cancer patient. A common preclinical approach to tackle this problem has been to characterize the tumors of patients at the molecular and drug response levels, and employ the resulting datasets for predictive in silico modeling (mostly using machine learning). Understanding how and why the different variants of these datasets are generated is an important component of this process.

View Article and Find Full Text PDF

is a commensal bacterium that causes severe infections in soft tissue and the bloodstream. During infection, manipulates host cell response to facilitate its own replication and dissemination. Here, we show that significantly decreases the level of SUMOylation, an essential post-translational modification, in infected macrophages 24 h post-phagocytosis.

View Article and Find Full Text PDF

NUPR1: A Critical Regulator of the Antioxidant System.

Cancers (Basel)

July 2021

Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, 163 Avenue de Luminy, 13288 Marseille, France.

Nuclear protein 1 (NUPR1) is a small intrinsically disordered protein (IDP) activated in response to various types of cellular stress, including endoplasmic reticulum (ER) stress and oxidative stress. Reactive oxygen species (ROS) are mainly produced during mitochondrial oxidative metabolism, and directly impact redox homeostasis and oxidative stress. Ferroptosis is a ROS-dependent programmed cell death driven by an iron-mediated redox reaction.

View Article and Find Full Text PDF

Novel partial loss-of-function variants in the tyrosyl-tRNA synthetase 1 (YARS1) gene involved in multisystem disease.

Eur J Med Genet

October 2021

Aix Marseille Univ, INSERM, MMG, Marseille, France; Service de Pédiatrie Multidisciplinaire, Hôpital de La Timone Enfants, APHM, Marseille, France. Electronic address:

Cytoplasmic aminoacyl-tRNA synthetases (ARSs) are emerging as a cause of numerous rare inherited diseases. Recently, biallelic variants in tyrosyl-tRNA synthetase 1 (YARS1) have been described in ten patients of three families with multi-systemic disease (failure to thrive, developmental delay, liver dysfunction, and lung cysts). Here, we report an additional subject with overlapping clinical findings, heterozygous for two novel variants in tyrosyl-tRNA synthetase 1 (NM_003680.

View Article and Find Full Text PDF

Squamousness gain defines pancreatic ductal adenocarcinoma hepatic metastases phenotype, and gemcitabine response.

Eur J Cancer

September 2021

Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, Marseille, France. Electronic address:

Background: Pancreatic ductal adenocarcinoma (PDAC) is a dismal disease with a survival rate of less than 7%, mainly due to the hepatic metastatic spread. Despite the importance of understanding PDAC metastases, central questions remain concerning their biology and chemosensitivity. Moreover, the transcriptomic divergence between primary tumor (PT) and hepatic metastases (HM) has been poorly studied and without a clear dissection of the confounding tumoral-surrounding tissue.

View Article and Find Full Text PDF

High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3B.

Am J Surg Pathol

October 2021

Pathology and Tumor Immunology, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm U1068, CNRS UMR7258, Aix-Marseille University, Marseille.

Although follicular lymphoma (FL) is usually graded as FL1-2, FL3A, and FL3B, some borderline cases can be observed and led us to investigate the clinicopathologic diversity of grade 3 FL (FL3). Among 2449 FL patients enrolled in Lymphoma Study Association (LYSA) trials, 1921 cases with sufficient material underwent a central pathologic review. The resulting diagnoses comprised 89.

View Article and Find Full Text PDF

The multikinase inhibitor sorafenib was the first drug approved by the FDA for treating patients with advanced hepatocellular carcinoma (HCC). However, sorafenib resistance remains a major challenge for improving the effectiveness of HCC treatment. Previously, we identified several genes modulated after sorafenib treatment of human HCC cells, including the stress-inducible nuclear protein 1 (NUPR1) gene.

View Article and Find Full Text PDF

Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME).

ESMO Open

August 2021

Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France; Aix-Marseille University, CNRS U7258, INSERM U1068, Institut Paoli-Calmettes, CRCM, Marseille, France. Electronic address:

Background: Primary inflammatory breast cancer (IBC) is a rare and aggressive entity whose prognosis has been improved by multimodal therapy. However, 5-year overall survival (OS) remains poor. Given its low incidence, the prognosis of IBC at metastatic stage is poorly described.

View Article and Find Full Text PDF

Crowding Effects on the Structure and Dynamics of the Intrinsically Disordered Nuclear Chromatin Protein NUPR1.

Front Mol Biosci

July 2021

Instituto de Biocomputación y Física de Sistemas Complejos (BIFI), Joint Units IQFR-CSIC-BIFI and GBsC-CSIC-BIFI, Universidad de Zaragoza, Zaragoza, Spain.

The intracellular environment is crowded with macromolecules, including sugars, proteins and nucleic acids. In the cytoplasm, crowding effects are capable of excluding up to 40% of the volume available to any macromolecule when compared to dilute conditions. NUPR1 is an intrinsically disordered protein (IDP) involved in cell-cycle regulation, stress-cell response, apoptosis processes, DNA binding and repair, chromatin remodeling and transcription.

View Article and Find Full Text PDF

Molecular characterization of fast-growing melanomas.

J Am Acad Dermatol

February 2022

Skin Cancer and Ageing Lab, Cancer Research United Kingdom Manchester Institute, The University of Manchester, Manchester, United Kingdom. Electronic address:

Article Synopsis
  • The study investigates the growth rates of primary cutaneous melanomas (≥1 mm thickness) and their link to aggressiveness, focusing on fast-growing melanomas (FGMM) versus slower ones.
  • Researchers evaluated the mutational profiles of these melanomas, finding that FGMM displayed a higher number of harmful mutations and poorer relapse-free survival rates.
  • Key factors associated with FGMM include ulceration, increased thickness, lower sun exposure, and specific mutations in the FGFR2 gene, suggesting that testing for FGFR2 could help identify patients at higher risk for aggressive disease.
View Article and Find Full Text PDF

BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells.

Cell Rep

July 2021

Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, 13009 Marseille, France; Institut Paoli-Calmettes, 13009 Marseille, France; Aix-Marseille Université UM105, CNRS UMR 7258, 13009 Marseille, France. Electronic address:

The anti-tumor response of Vγ9Vδ2 T cells requires the sensing of accumulated phosphoantigens (pAgs) bound intracellularly to butyrophilin 3A1 (BTN3A1). In this study, we show that butyrophilin 2A1 (BTN2A1) is required for BTN3A-mediated Vγ9Vδ2 T cell cytotoxicity against cancer cells, and that expression of the BTN2A1/BTN3A1 complex is sufficient to trigger Vγ9Vδ2 TCR activation. Also, BTN2A1 interacts with all isoforms of BTN3A (BTN3A1, BTN3A2, BTN3A3), which appears to be a rate-limiting factor to BTN2A1 export to the plasma membrane.

View Article and Find Full Text PDF
Article Synopsis
  • Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with a low 5-year survival rate, and recent studies have highlighted the importance of epigenomic changes, particularly the H3K9me pathway, in its progression.
  • The enzyme EHMT2, responsible for producing H3K9me, acts as a crucial mediator of oncogenic KRAS during both PDAC initiation and inflammation-related promotion, with its inactivation showing potential to hinder tumor growth in models.
  • Findings indicate that EHMT2's role includes enhancing cancer cell senescence and lowering inflammatory responses associated with KRAS-driven tumor processes, underlining a significant KRAS-EHMT2 interaction in PDAC pathology.
View Article and Find Full Text PDF

The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience.

Eur J Cancer

September 2021

Department of Pediatric Immunology, Hematology and Oncology, Children Hospital of La Timone, AP-HM, Marseille, France; SMARTc Unit, Centre de Recherche en Cancérologie de Marseille, Inserm U1068, Aix Marseille Univ, Marseille France. Electronic address:

Background And Aims: COVID-19 infection in paediatric patients with cancer is severe or critical in 20% of the patients. It can therefore directly affect paediatric patients with cancer and/or their care. We aimed at evaluating the safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults (AYA) with solid tumour.

View Article and Find Full Text PDF

The Cellular and Biological Impact of Extracellular Vesicles in Pancreatic Cancer.

Cancers (Basel)

June 2021

INSERM, U1068, Cancer Research Center of Marseille, Institut Paoli-Calmettes, CNRS, UMR7258, University Aix-Marseille, 13009 Marseille, France.

Deciphering the interactions between tumor and stromal cells is a growing field of research to improve pancreatic cancer-associated therapies and patients' care. Indeed, while accounting for 50 to 90% of the tumor mass, many pieces of evidence reported that beyond their structural role, the non-tumoral cells composing the intra-tumoral microenvironment influence tumor cells' proliferation, metabolism, cell death and resistance to therapies, among others. Simultaneously, tumor cells can influence non-tumoral neighboring or distant cells in order to shape a tumor-supportive and immunosuppressive environment as well as influencing the formation of metastatic niches.

View Article and Find Full Text PDF

Protein Kinases in Leukemias.

Cancers (Basel)

June 2021

INSERM U1035 BMGIC, Université de Bordeaux, 33076 Bordeaux, France.

Protein kinases (PK) make up around 2% of the human genome and their expression profile varies depending on the organ and tissue [...

View Article and Find Full Text PDF

Endometrial cancer (EC) can easily be cured when diagnosed at an early stage. However, advanced and metastatic EC is a common disease, affecting more than 15,000 patients per year in the United Sates. Only limited treatment options were available until recently, with a taxane-platinum combination as the gold standard in first-line setting and no efficient second-line chemotherapy or hormone therapy.

View Article and Find Full Text PDF